Kymera Therapeutics, Inc. (KYMR) Earnings
NASDAQ·Healthcare·Biotechnology
$118.10
+2.84%
Mkt Cap $9.12B
EPS — Estimate vs Actual
Mkt Cap
$9.12B
P/E
—
Fwd P/E
—
P/S
177.17
Rev TTM
—
EPS TTM
-$3.58
NASDAQ·Healthcare·Biotechnology
$118.10
+2.84%
Mkt Cap $9.12B
Mkt Cap
$9.12B
P/E
—
Fwd P/E
—
P/S
177.17
Rev TTM
—
EPS TTM
-$3.58